Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
AMYLYX PHARMACEUTICALS, INC.
About AMLX
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on four investigational therapies across several diseases. Its lead investigational asset is avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist. Avexitide has been evaluated as a treatment for Post-Bariatric Hypoglycemia (PBH) and congenital HI, two indications characterized by hyperinsulinemic hypoglycemia. In addition to avexitide, it is advancing AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol in Wolfram syndrome, AMX0114 in amyotrophic lateral sclerosis (ALS), and AMX0318 in PBH and other rare diseases. AMX0035 is designed to mitigate neurodegeneration by targeting endoplasmic reticulum stress and mitochondrial dysfunction, two cellular processes central to neuronal cell death and neurodegeneration. AMX0114 is an investigational antisense oligonucleotide and AMX0318 is a novel GLP-1 receptor antagonist.
Find out what a historical investment in AMYLYX PHARMACEUTICALS, INC. would be worth today using our AMLX stock calculator.
Market Capitalisation
$1.42B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.7M
High today
$13.71
Low today
$12.81
Open price
$12.93
52-week high
$18.61
52-week low
$4.64
Ready to start your investing journey with Stake?
Open an accountHow do I buy AMLX shares in Australia?
Buying AMLX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in AMYLYX PHARMACEUTICALS, INC. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AMLX
What is the ticker symbol of AMYLYX PHARMACEUTICALS, INC.?
The ticker symbol for AMYLYX PHARMACEUTICALS, INC. is AMLX.
How much is one share of AMLX?
One share of AMLX is valued at $13.57 as of 20 May 2026.
What is the market capitalisation of AMYLYX PHARMACEUTICALS, INC. AMLX?
As of 20 May 2026 AMYLYX PHARMACEUTICALS, INC. has a market cap of $1.42B.
What is the 52-week high for AMYLYX PHARMACEUTICALS, INC. stock?
The AMYLYX PHARMACEUTICALS, INC. 52-week high stock price is $18.61.
What is the 52-week low for AMYLYX PHARMACEUTICALS, INC. stock?
The AMYLYX PHARMACEUTICALS, INC. 52-week low stock price is $4.64.
Can I buy AMLX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AMLX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AMLX on Stake
- Buy AMLX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AMLX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AMLX related stocks